If This Turns Out To Be True -- Quite A Story (Non-Bakken, Non-Energy) - July 10, 2017

Meningococcal vaccine may offer protection against gonorrhea. Link to story here.

With some exceptions, most states mandate meningococcal vaccination for those attending colleges or universities. The US military mandates this vaccination.

Despite the fact that gonorrhea and meningitis are quite different from one another, the bacteria that cause Neisseria gonorrhoeae and Neisseria meningitidis are actually related.

From the linked story:

The research, conducted in New Zealand, found that the gonorrhea rate among teens and young adults there who had received a meningitis B vaccine during an emergency campaign in the early 2000s was significantly lower than the rate seen in people of the same age who weren’t vaccinated.

****************************

The Stock Market

I wasn't paying attention to CNBC today. Checking something tonight brought me to this -- it was posted early this morning, before the market opened.

I couldn't find any news regarding XLNX but apparently "the Nvidia story" was the story driving everything. Then over at Investor's Business Daily, this headline and story:

These four sectors lead market higher; Amazon hurts retailers. Key U.S. index funds held modest gains Monday as tech stocks led the upside. Nvidia (NVDA) and Xilinx (XLNX) boosted chip ETFs.

Wow. One doesn't see XLNX at the top of these lists often. (Ever?)

Disclaimer: this is not an investment site. Do not make any investment, financial, job, relationship, or travel decisions based on what you read here or what you think you may have read here. If this is important to you, go to the source.